
Vaxxinova US gains market rights to SRP cattle vaccine from Zoetis
Dec 16, 2020 – Wilmar, MN, USA Vaxxinova US has acquired marketing rights from Zoetis for a vaccine against Salmonella in cattle. Until now, the SRP Salmonella vaccine – the first USDA-licensed vaccine to use SRP technology – was manufactured by Vaxxinova US but marketed by Zoetis. With the latest license acquisition, Vaxxinova US now […]
Read more →

“Boerderij” article on autogenous vaccines
Dutch farmers Magazine “Boerderij” published an article on autogenous vaccines in its June 16, 2020 edition. The article mentions how autogenous vaccines can contribute to reduced antibiotic use in swine and Vaxxinova’s contribution to this. Read the full article here.
Read more →

Vaxxinova announces Director R&D and Director RA
Nijmegen, The Netherlands, Wednesday June 3, 2020. Vaxxinova® Nederland BV is pleased to announce two new directors to its team as per June 1, 2020. Both positions are based in Nijmegen. Mrs. Mirjam van der Sluijs will take up the role of Director R&D Nijmegen. As Director R&D Nijmegen Mirjam will lead the R&D and […]
Read more →
Vaxxinova®
Vaxxinova® is committed to disease prevention in livestock. We aim to provide a complete set of vaccines and diagnostic services, supported by our global R&D network. Vaxxinova believes in ‘business without borders’ and long term partnerships with livestock veterinarians and animal health professionals. We work together in disease prevention and livestock performance improvement programs. Our technical teams can advise you on our products and services.